NCT01339065

Brief Summary

. Null Hypothesis: Giving low doze ketamine (0.5mg/kg) given preoperatively to adult patients undergoing elective surgery, in Mulago hospital, will not have a reduction effect on the levels of IL-6 \& IL-1β pro inflammatory markers by 48 hours. . Alternate Hypothesis: Giving low doze ketamine (0.5mg/kg) given preoperatively to adult patients undergoing elective surgery, in Mulago hospital, will have a reduction effect on the levels of IL-6 \& IL-1β pro inflammatory markers by 48 hours.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Apr 2011

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

April 19, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 20, 2011

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
Last Updated

April 20, 2011

Status Verified

April 1, 2011

Enrollment Period

1 month

First QC Date

April 19, 2011

Last Update Submit

April 19, 2011

Conditions

Keywords

ketamineinflammatorypro inflammatorypro inflammatory markers IL-6 and IL-1beta

Outcome Measures

Primary Outcomes (1)

  • changes/deviations from baseline levels of IL-6 pro-inflammatory markers of after surgery

    changes/deviations from baseline levels of IL-6 pro-inflammatory markers of after surgery at Post Anesthesia Care Unit, 24 and 48 hours

    48 hours

Secondary Outcomes (1)

  • changes/deviations from baseline levels of IL-1β pro-inflammatory markers of after surgery

    48 hours

Study Arms (2)

Ketamine

ACTIVE COMPARATOR

will be given low sub-anesthetic doses of Ketamine 0.5mg/kg.

Drug: Ketamine

Placebo

PLACEBO COMPARATOR

will get placebo treatment

Drug: Ketamine

Interventions

determining the effect of low dose sub anesthetic doze of ketamine and placaebo on post operative patients

KetaminePlacebo

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consented patients due for elective surgery
  • Adult patients 18- 70 year old
  • ASA I- ASA II scoring patients, who are normal patients or those with mild systemic illness

You may not qualify if:

  • Emergency cases that will already have high levels of inflammatory markers secreted in their system by incision time e.g. road traffic accidents
  • Patients with chronic / severe hypertension
  • Febrile Patients (T \>38°C)
  • Persistently raised blood pressures above 140/90 for 2 consistent readings 15 minutes apart
  • Patients with pheochromocytoma
  • Spinal and local infiltration anaesthesia cases
  • Neuro surgery patients whom Ketamine is contra indicated
  • Epilepsy patients
  • ASA IIIE and above
  • Patients receiving Aspirin prophylaxis
  • Chronic inflammatory disease states such as hyperparathyroidism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mulago Hospital National Refferal, surgical wards

Kampala, +256, Uganda

RECRUITING

Related Publications (1)

  • Luggya TS, Roche T, Ssemogerere L, Kintu A, Kasumba JM, Kwizera A, Tindimwebwa JV. Effect of low-dose ketamine on post-operative serum IL-6 production among elective surgical patients: a randomized clinical trial. Afr Health Sci. 2017 Jun;17(2):500-507. doi: 10.4314/ahs.v17i2.25.

MeSH Terms

Interventions

Ketamine

Intervention Hierarchy (Ancestors)

CyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 19, 2011

First Posted

April 20, 2011

Study Start

April 1, 2011

Primary Completion

May 1, 2011

Study Completion

June 1, 2011

Last Updated

April 20, 2011

Record last verified: 2011-04

Locations